Humacyte Other Current Assets vs Non Currrent Assets Other Analysis

HUMAW Stock  USD 1.50  0.19  11.24%   
Humacyte financial indicator trend analysis is much more than just examining Humacyte latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Humacyte is a good investment. Please check the relationship between Humacyte Other Current Assets and its Non Currrent Assets Other accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Other Current Assets vs Non Currrent Assets Other

Other Current Assets vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Humacyte Other Current Assets account and Non Currrent Assets Other. At this time, the significance of the direction appears to have strong relationship.
The correlation between Humacyte's Other Current Assets and Non Currrent Assets Other is 0.7. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Humacyte, assuming nothing else is changed. The correlation between historical values of Humacyte's Other Current Assets and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Humacyte are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Other Current Assets i.e., Humacyte's Other Current Assets and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.7
Relationship DirectionPositive 
Relationship StrengthSignificant

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Humacyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Humacyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.Enterprise Value is likely to climb to about 255.9 M in 2025, whereas Selling General Administrative is likely to drop slightly above 21.1 M in 2025.
 2022 2023 2024 2025 (projected)
Interest Expense6.2M1.1M1.3M1.2M
Depreciation And Amortization8.3M7.7M8.9M8.7M

Humacyte fundamental ratios Correlations

0.15-0.09-0.090.5-0.09-0.87-0.01-0.250.97-0.09-0.070.97-0.050.01-0.230.060.40.32-0.230.970.75-0.08-0.080.17-0.08
0.150.560.89-0.21-0.970.11-0.920.60.36-0.970.90.37-0.880.940.21-0.860.880.980.230.380.39-0.48-0.480.99-0.48
-0.090.560.590.39-0.450.24-0.40.720.01-0.450.580.0-0.170.63-0.55-0.530.210.47-0.530.0-0.22-0.34-0.340.6-0.34
-0.090.890.59-0.19-0.910.31-0.830.580.12-0.910.850.12-0.810.990.1-0.960.80.860.120.130.27-0.47-0.470.86-0.47
0.5-0.210.39-0.190.33-0.570.4-0.130.420.33-0.30.410.55-0.1-0.950.18-0.19-0.12-0.950.40.130.190.19-0.170.19
-0.09-0.97-0.45-0.910.33-0.230.97-0.63-0.31.0-0.94-0.310.95-0.92-0.320.92-0.9-0.95-0.34-0.32-0.360.60.6-0.950.6
-0.870.110.240.31-0.57-0.23-0.320.63-0.81-0.230.45-0.81-0.240.190.29-0.34-0.16-0.070.29-0.8-0.74-0.42-0.420.11-0.42
-0.01-0.92-0.4-0.830.40.97-0.32-0.69-0.220.97-0.96-0.230.94-0.85-0.370.89-0.82-0.88-0.39-0.24-0.240.60.6-0.920.6
-0.250.60.720.58-0.13-0.630.63-0.69-0.15-0.630.85-0.15-0.470.56-0.04-0.630.260.46-0.03-0.14-0.41-0.79-0.790.64-0.79
0.970.360.010.120.42-0.3-0.81-0.22-0.15-0.30.121.0-0.260.24-0.16-0.150.60.53-0.151.00.83-0.13-0.130.37-0.13
-0.09-0.97-0.45-0.910.331.0-0.230.97-0.63-0.3-0.94-0.310.95-0.92-0.320.92-0.9-0.95-0.34-0.32-0.360.60.6-0.950.6
-0.070.90.580.85-0.3-0.940.45-0.960.850.12-0.940.12-0.850.850.21-0.890.70.820.230.130.04-0.72-0.720.91-0.72
0.970.370.00.120.41-0.31-0.81-0.23-0.151.0-0.310.12-0.260.23-0.14-0.150.60.53-0.131.00.84-0.13-0.130.38-0.13
-0.05-0.88-0.17-0.810.550.95-0.240.94-0.47-0.260.95-0.85-0.26-0.81-0.570.83-0.89-0.87-0.59-0.28-0.410.520.52-0.850.52
0.010.940.630.99-0.1-0.920.19-0.850.560.24-0.920.850.23-0.810.04-0.950.840.920.070.250.34-0.41-0.410.91-0.41
-0.230.21-0.550.1-0.95-0.320.29-0.37-0.04-0.16-0.320.21-0.14-0.570.04-0.090.30.181.0-0.130.12-0.12-0.120.17-0.12
0.06-0.86-0.53-0.960.180.92-0.340.89-0.63-0.150.92-0.89-0.150.83-0.95-0.09-0.8-0.84-0.11-0.16-0.250.550.55-0.840.55
0.40.880.210.8-0.19-0.9-0.16-0.820.260.6-0.90.70.6-0.890.840.3-0.80.950.320.610.73-0.39-0.390.84-0.39
0.320.980.470.86-0.12-0.95-0.07-0.880.460.53-0.950.820.53-0.870.920.18-0.840.950.20.540.57-0.42-0.420.96-0.42
-0.230.23-0.530.12-0.95-0.340.29-0.39-0.03-0.15-0.340.23-0.13-0.590.071.0-0.110.320.2-0.130.13-0.13-0.130.19-0.13
0.970.380.00.130.4-0.32-0.8-0.24-0.141.0-0.320.131.0-0.280.25-0.13-0.160.610.54-0.130.84-0.14-0.140.39-0.14
0.750.39-0.220.270.13-0.36-0.74-0.24-0.410.83-0.360.040.84-0.410.340.12-0.250.730.570.130.840.130.130.350.13
-0.08-0.48-0.34-0.470.190.6-0.420.6-0.79-0.130.6-0.72-0.130.52-0.41-0.120.55-0.39-0.42-0.13-0.140.131.0-0.491.0
-0.08-0.48-0.34-0.470.190.6-0.420.6-0.79-0.130.6-0.72-0.130.52-0.41-0.120.55-0.39-0.42-0.13-0.140.131.0-0.491.0
0.170.990.60.86-0.17-0.950.11-0.920.640.37-0.950.910.38-0.850.910.17-0.840.840.960.190.390.35-0.49-0.49-0.49
-0.08-0.48-0.34-0.470.190.6-0.420.6-0.79-0.130.6-0.72-0.130.52-0.41-0.120.55-0.39-0.42-0.13-0.140.131.01.0-0.49
Click cells to compare fundamentals

Humacyte Account Relationship Matchups

Humacyte fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets106.7M286.5M204.3M128.2M147.5M196.8M
Short Long Term Debt Total28.9M48.5M47.8M57.5M66.1M45.8M
Other Current Liab4.6M6.8M7.1M9.3M10.7M7.8M
Total Current Liabilities11.2M11.1M19.6M18.4M21.2M15.7M
Total Stockholder Equity(350.3M)122.2M116.9M13.5M15.6M16.4M
Property Plant And Equipment Net65.2M57.2M50.1M44.9M40.5M46.6M
Net Debt(11.1M)(169.0M)(102.0M)(22.9M)(20.6M)(21.7M)
Retained Earnings(388.1M)(414.6M)(426.5M)(537.3M)(483.6M)(507.8M)
Accounts Payable2.3M2.1M1.6M6.5M7.5M7.8M
Cash39.9M217.5M149.8M80.4M92.5M127.9M
Non Current Assets Total65.2M57.2M50.1M44.9M40.5M46.6M
Non Currrent Assets Other(65.2M)(57.2M)(50.1M)32K36.8K38.6K
Cash And Short Term Investments39.9M225.5M151.9M80.4M92.5M130.1M
Common Stock Shares Outstanding12.4M40.0M103.1M103.4M118.9M61.4M
Liabilities And Stockholders Equity106.7M286.5M204.3M128.2M147.5M196.8M
Non Current Liabilities Total445.8M153.3M67.8M96.2M86.6M126.2M
Other Current Assets1.4M3.7M4.6M2.8M3.3M2.9M
Other Stockholder Equity37.8M536.7M543.5M550.9M633.5M374.3M
Total Liab457.0M164.4M87.4M114.7M103.2M137.6M
Total Current Assets41.4M229.3M154.2M83.3M95.8M132.7M
Common Stock1K536.7M543.5M10K11.5K10.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.